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Genetic damage elicits stress-related
responses that may alter the expression of
genes associated with numerous biological
pathways (Hollander and Fornace 1995). It
has been proposed that patterns of induced
gene expression changes may be character-
istic of speciﬁc classes of toxic compounds
and that distinctive fingerprints may be
identiﬁed that help classify agents with dif-
ferent mechanisms of action (Hamadeh
et al. 2002a, 2002b; Waring et al. 2001a,
2001b). Historically, the expression of bac-
terial SOS response genes was used for
detecting genotoxicity of chemicals. The
bacterial DNA repair pathways have been
well characterized, and various genes have
been used as indicators of the SOS
response. In these assays (Ben-Israel et al.
1998; Nunoshiba and Nishioka 1991; Oda
et al. 1985; Ptitsyn et al. 1997; Quillardet
et al. 1982), the transcriptional activities of
SOS response–associated genes have been
detected using promoter–reporter con-
structs (biosensors). Thus, each bacterial
tester strain carried a construct capable of
detecting induction of a single SOS-
response pathway. An array of cell lines
covering multiple genotoxic stress–associ-
ated pathways provided even more insight
into bacterial genotoxic mechanisms. A
similar approach also has been applied to
human cells using an array of HepG2 cell
lines carrying genotoxic stress–associated
promoter or response element–reporter
gene fusion constructs (Todd et al. 1995).
The simultaneous treatment of these cell
lines provided a genotoxic stress–associated
gene expression profile in human cells
exposed to various chemicals (Todd et al.
1995) and environmental pollutants
(Vincent et al. 1997). In drug discovery,
the array of cell lines has been used success-
fully in the study of the mechanism of
genotoxicity of organometallic cytostatics
(Aubrecht et al. 1999). However, recent
development of oligonucleotide and cDNA
microarrays for large-scale parallel gene
expression profiling will make the cell-
based promoter–reporter arrays obsolete. In
contrast to biosensor cell lines that cover a
limited number of biological pathways,
gene expression microarrays allow measure-
ment and characterization of genomewide
gene expression changes in a single experi-
ment. As such, toxicogenomic studies are
expected to have a large impact on the ﬁeld
of genetic toxicologys as discussed by
Aardema and MacGregor (2002).
In this overview we provide a summary
of research activities of the Genotoxicity
Working Group of the International Life
Sciences Institute (ILSI) Health and
Environmental Sciences Institute (HESI)
Committee on the Application of
Genomics to Mechanism-Based Risk
Assessment. A description of the overall
objectives and design of the committee is
included in this mini-monograph (Pennie
et al. 2004). The HESI Genotoxicity
Working Group is an international collab-
orative effort that includes scientists from
industry, academia, government, and regu-
latory agencies (Table 1). The major objec-
tive of the collaborative project was to
evaluate the utility of gene expression pro-
ﬁle analysis for risk assessment of genotoxi-
cants. The group analyzed gene expression
proﬁles of compounds with known mecha-
nisms of genotoxicity to determine whether
compounds from different mechanistic
classes display distinct gene expression pro-
files. Particular focus was on identifying
genes that discriminate between non-
DNA–interactive compounds (initial target
is not DNA) from DNA-interactive geno-
toxicants. By examining compounds with
known mechanisms and well-characterized
mutagenic activities, we attempted to
address the issue of whether gene expres-
sion changes provide useful information for
understanding how a compound exerts its
genotoxic effects. Other important compo-
nents of our evaluation were to ensure that
one could distinguish a genotoxicity proﬁle
from a cytotoxicity profile and to evaluate
the value of the technology for examining
low-dose effects of genotoxic agents. The
Genotoxicity Working Group also exam-
ined the correlation of measured gene
expression changes via microarrays with
traditional genetic toxicology end points.
Similarly, a secondary question was
whether microarray technologies could be a
useful adjunct to the standard genotoxicity
test battery. 
Experimental Overview
To determine if gene expression patterns
can be correlated with mechanisms of
action of genotoxicants, we have generated
gene expression profiles for several model
genotoxic agents. Studies were conducted
in the absence of S9 metabolic activation
using two different cell lines employed in
standard genotoxicity testing [L5178Y
mouse lymphoma and human thymidine
kinase (TK) 6 cells]. The mouse lymphoma
cells used were p53 deficient, whereas the
human TK6 cells were p53 proﬁcient. The
test agents, whose primary mechanisms are
denoted, included a methylating agent
[methyl ester methanesulfonic acid
(MMS)]; DNA cross-linking agents (mito-
mycin C and cisplatin); DNA adduct
inducers [benzo[a]pyrene diolepoxide
(BPDE)] and 4-nitroquinoline oxide); free-
radical generators [bleomycin and hydro-
gen peroxide (H2O2)]; a microtubule
inhibitor (taxol); a topoisomerase inhibitor
(etoposide); and a compound that perturbs
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Most of the test chemicals listed above
were evaluated in at least two separate labo-
ratory sites. At least two independent repli-
cate studies were conducted in each
laboratory. The experimental parameters
were designed to mimic a standard genetic
toxicology assay. Two time points were
examined; cells were treated for 4 hr and
immediately harvested for RNA isolation, or
cells were treated for 4 hr and allowed to
recover for 20 hr (24-hr time point) before
being harvested. At least two concentration
levels of each test article were tested. A high
concentration that induced 70–80% cyto-
toxicity (for a TK gene mutation assay) or
approximately 50% cytotoxicity (for a
micronucleus assay) with a robust induction
of genotoxicity and a low concentration that
produced limited cytotoxicity (10–30%)
with a 1.5- to 4-fold increase in genotoxicity
(gene mutations, chromosomal damage, or
DNA adducts) were used. The relative
reduction of cell growth compared with the
negative control was used as a measure of
cytotoxicity. The gene expression changes
were detected using GeneChip oligo-
nucleotide arrays (Affymetrix, Inc., Santa
Clara, CA), PHASE-1 cDNA microarrays
(PHASE-1 Molecular Toxicology, Inc.,
Santa Fe, NM), or Atlas cDNA microarrays
(Clontech, Palo Alto, CA). Potential sources
of variability such as the lot of test chemical,
tissue culture reagents, or DNA microarrays
were not rigorously controlled in order to
assess the potential impact of these factors in
a real-life situation where standardization of
all reagents would not be possible.
Discussion and Conclusions
Although data analysis efforts continue,
results to date have enabled us to make
some initial conclusions. For most of the
compounds evaluated in this study, few
reproducible gene changes occurred at low
concentrations and the early time point
(4 hr), whereas a greater number of changes
were observed at the higher dose levels
and/or the 24-hr time point. Changes
>3 -fold were not common even at highly
genotoxic concentrations. These observa-
tions were made in all the participating lab-
oratories. Nevertheless, gene expression
changes of a few biologically relevant genes,
including members of the GADD45 family,
showed robust upregulation (3- to 14-fold)
at cytotoxic doses. Some of the participat-
ing laboratories identified significant gene
changes on the basis of fold-change criteria
(1.5-fold or more), whereas other laborato-
ries used statistical methods for establishing
whether the expression of a particular gene
was changed significantly. On the basis of
these results, it appears that early concerns
that the technology might be overly sensi-
tive (numerous, large-fold changes in gene
expression changes at low or nongenotoxic
concentrations) are unfounded. 
The extent of gene expression changes
resulting from treatment was not as sensi-
tive an end point as those provided by
more traditional genetic toxicology assays.
For example, Aubrecht and colleagues
(unpublished data) found that higher con-
centrations of cisplatin were required to see
robust gene expression changes on a
microarray platform compared with levels
that induced micronuclei in vitro.
Conversely, the gene expression changes of
biologically relevant genes such as members
of the GADD45 family showed excellent
correlation with the extent of DNA–
platinum adducts and protein–DNA cross-
links. Morris and colleagues (unpublished
data) found that induction of DNA
adducts occurred at lower concentrations
for BPDE than at those concentrations that
elicited robust gene expression changes.
These examples show that the induction of
gene expression changes as measured by
microarrays is not as sensitive an indicator
of genotoxicity when compared with more
traditional genotoxicity end points. 
Observed changes in gene expression
from the Genotoxicity Working Group
studies were generally consistent with data
in the literature for those chemicals studied
previously. For example, with MMS many
of the categories of the gene expression
changes observed by the working group
were consistent with those reported for
yeast in the literature (Jelinsky et al. 2000;
Jelinsky and Samson 1999). These studies
suggested that in addition to inducing
DNA-damage recovery genes, mammalian
cells also induce genes to promote recovery
from protein damage such as endoplasmic
reticulum stress and/or unfolded protein
response. Some of the genes identified in
our studies are concordant with genes from
the same biological pathways affected in
yeast. However, yeast studies on global
transcriptional responses to environmental
stresses including MMS revealed that
10–14% of all genes are induced or
repressed in response to a wide range of
stresses. We did not see such an encom-
passing gene expression response in the
mammalian cell lines used for our studies.
It is unclear whether this less-robust
response is a by-product of high noise-to-
signal ratios associated with the microarrays
or to the biology of an in vitro gene expres-
sion stress response in mammalian cells. 
Our data indicate that gene expression
changes may enable us to distinguish classes
of genotoxic compounds that operate via
different modes of action. Prior to the
HESI project, this concept had been
explored by Fornace and co-workers using a
panel of human cancer cell lines to catego-
rize different stress agents by gene expres-
sion profiling using directed arrays
(Amundson et al. 1999; Fornace et al.
1999). In an alternative approach, Aubrecht
and colleagues (1999) used a panel of
biosensor cell lines to investigate mecha-
nism of genotoxicity of organometallic
cytostatics. This latter concept was devel-
oped and demonstrated in the early 1990s
by Spencer Farr and others using both bac-
terial and mammalian cell constructs to
monitor stress gene responses (MacGregor
et al. 1995). On the basis of these early
studies, the HESI Genotoxicity Working
Group hypothesized that gene expression
changes could be identified that discrimi-
nate broad classes of genotoxicants, includ-
ing DNA-reactive genotoxicants from
non-DNA-reactive (or indirect) genotoxi-
cants. Aardema and colleagues (unpub-
lished data) compared gene expression
patterns using a supervised statistical
approach with DNA-interactive genotoxic
agents (MMS, mitomycin C, and cisplatin)
versus three compounds that act via a non-
DNA–interactive mechanism (hydroxyurea,
taxol, and etoposide). This comparison
resulted in a ﬁngerprint that discriminated
the two classes of chemicals on the basis of a
training set of genes for the two time
points. When this training set of genes was
applied to data from chemicals tested in
other laboratories, this fingerprint led to
correct identiﬁcation of chemicals as DNA
interactive or non–DNA interactive in
approximately 80% of the cases. Aardema
and colleagues are analyzing additional data
to help validate the utility of this approach.
In addition, Gollapudi and colleagues
reported certain gene expression changes
that could serve as biomarkers of exposure
to free radical–generating agents on the
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Table 1. List of participating organizations in the
HESI Genotoxicity Working Group.
AstraZeneca Pharmaceuticals Inc.
Aventis Pharmaceuticals Inc.
Biogen, Inc.
The Dow Chemical Co.
E.I. duPont de Nemours & Co.
Eli Lilly and Co.
GlaxoSmithKline
Johnson & Johnson Pharmaceutical Research and 
Development, LLC
Monsanto Co.
National Institute of Health Sciences, Japan
Novartis Pharmaceuticals AG
Pﬁzer Inc, Global Research and Development
The Procter & Gamble Co.
Sankyo Company Ltd.
Sanoﬁ-Synthélabo, Inc.
U.S. National Cancer Institute
U.S. National Center for Toxicological ResearchMini-Monograph | Newton et al.
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basis of their studies with bleomycin and
H2O2 (Seidel et al. 2003). Some prelimi-
nary results indicate that even within a cate-
gory, namely, indirect-acting genotoxicants
(hydroxyurea and taxol), differences exist in
the gene expression patterns generated by
these two compounds. These differences are
not surprising, as the primary cellular
targets are quite distinct. 
Aubrecht and colleagues (unpublished
data) found that the gene expression proﬁle
of sodium chloride at micronucleus-
producing concentrations was strikingly
different from the proﬁle of cisplatin. The
most notable difference was the lack of
upregulation of DNA damage–sensitive
genes such as GADD45 and cFOS in
sodium chloride–treated cells. In an addi-
tional study, Gollapudi and co-workers
(unpublished data) observed that the gene
expression changes observed in sodium
chloride–treated cells were qualitatively dif-
ferent from those observed in MMS-
treated cells, with only one gene common
to both the treatments. Testing of addi-
tional cytotoxic and genotoxic compounds
is needed to conﬁrm this ability to differen-
tiate the two types of responses. 
After their initial experience, the work-
ing group concluded that microarray tech-
nologies are not currently amenable for use
as a high-throughput screening tool for
genotoxicity. The data analysis is quite
complicated; there are numerous sources of
variability; the sensitivity of the technique
appears to be less than standard genotoxic-
ity measures; and the arrays are still fairly
expensive. High-throughput approaches
could be facilitated in the future with the
development of more targeted arrays.
These focused arrays might contain only a
few highly biologically relevant genotoxic
response genes as identified from previous
experience with large global arrays. This
approach could be used to examine a par-
ticular biological mechanism in a high-
throughput screening paradigm. 
For the Genotoxicity Working Group,
as well as for other investigators in the ﬁeld
of toxicogenomics, a significant challenge
has been the variation in approaches to
data presentation and analysis across labo-
ratories. Other sources of interlaboratory
differences included variables such as the
day RNA samples were processed, the pho-
tomultiplier tube adjustment, use of differ-
ent lots of chips, use of different platforms
(Affymetrix or PHASE-1 arrays), and dif-
ferent culture conditions for these in vitro
studies. All these factors affect the out-
comes of studies performed in different
laboratories. Further analysis of the
interlaboratory variability issue is under
way to determine how much each variable
impacts the results of the studies. 
The pending public release of the HESI
Genomics Committee’s experimental data
as part of the European Bioinformatics
Institute’s ArrayExpress database (http://
www.ebi.ac.uk/arrayexpress) will allow the
scientific community to evaluate the raw
data of the consortium in alternative ways.
Currently, an effort is under way within the
Genotoxicity Working Group to evaluate
various data analysis approaches including
Affymetrix Microarray Suite 5.0, Rosetta
Resolver, or other statistical approaches. To
facilitate data analysis issues, more straight-
forward, easy-to-use bioinformatic tools
need to be developed that provide a com-
mon format for data comparison between
studies and across different laboratories. For
investigators to fully utilize information
from these studies, it is essential that user-
friendly data-mining tools be developed
that enable critical genes in relevant biologi-
cal pathways (e.g., those involved in a geno-
toxic response) to be identiﬁed. 
In summary, our data indicate that the
value of the gene expression proﬁling tech-
nology is its potential to provide mechanis-
tic insight into the mode of action of a
genotoxic compound. The use of the tech-
nology to differentiate compounds that
interact directly with DNA from those com-
pounds that are genotoxic via a secondary
mechanism is considered one of the valuable
aspects of this tool and provides an alterna-
tive methodology to help discriminate
agents that act by deﬁned modes of action.
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